OFFICIAL PUBLICATION OF

by its subsidiary APPco

Ozempic shortages to continue: Butler

Nicholas O’Donoghue 16/07/2024

Novo Nordisk “simply doesn’t have the factories” to meet growing demand for Ozempic, Health Minister says Shortages of Novo Nordisk’s diabetes medication, Ozempic (semaglutide) are likely to continue into 2025, while hormone replacement patches could be resolved by September, Mark Butler the Minister for Health and Aged Care warns. Speaking with Heidi Murphy on 3AW

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Ozempic shortages to continue: Butler

Previous Research Roundup

Next NAPSA seeks new chairs

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Research Roundup

Next NAPSA seeks new chairs

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.